Universal Biosensors, Inc. (ASX:UBIO)
0.0400
0.00 (0.00%)
At close: Dec 13, 2024
Universal Biosensors Revenue
Universal Biosensors had revenue of 1.55M AUD in the quarter ending March 31, 2025, with 5.79% growth. This brings the company's revenue in the last twelve months to 6.37M, down -6.45% year-over-year. In the year 2024, Universal Biosensors had annual revenue of 6.28M, down -5.28%.
Revenue (ttm)
6.37M
Revenue Growth
-6.45%
P/S Ratio
1.69
Revenue / Employee
83.79K
Employees
76
Market Cap
10.73M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.28M | -350.10K | -5.28% |
Dec 31, 2023 | 6.63M | 2.11M | 46.58% |
Dec 31, 2022 | 4.52M | -1.25M | -21.68% |
Dec 31, 2021 | 5.78M | 2.58M | 80.41% |
Dec 31, 2020 | 3.20M | -3.69M | -53.57% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Commonwealth Bank of Australia | 26.73B |
BHP Group | 87.21B |
National Australia Bank | 20.05B |
CSL Limited | 24.61B |
Westpac Banking | 21.37B |
Wesfarmers | 45.01B |
ANZ Group Holdings | 21.10B |
Macquarie Group | 17.32B |